Clinical Trial Update: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]

View source ↗

Summary

A Phase 1 trial update reporting on the safety and tolerability assessment of PMC-403 in subjects with neovascular age-related macular degeneration; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• PMC-403

Snippet

Sponsor: PharmAbcine | Conditions: Neovascular Age-related Macular Degeneration | Phase 1 | Status: COMPLETED